Technical Chemicals and Products (TCPI) sees share price drop over glucose monitor
This article was originally published in Clinica
Technical Chemicals and Products, which is in clinical trials with a non-invasive glucose monitor, has hit out at erroneous impressions that its product may be linked with the problems surrounding Johnson & Johnson's LifeScan SureStep.
You may also be interested in...
As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.
In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.
While good clinical practice inspectors in the UK and the US collaborate on matters of common interest, they say that mutual recognition is simply not possible.